Division of General Internal Medicine Hypertension Impact Project - - PowerPoint PPT Presentation

division of general internal medicine
SMART_READER_LITE
LIVE PREVIEW

Division of General Internal Medicine Hypertension Impact Project - - PowerPoint PPT Presentation

Division of General Internal Medicine Hypertension Impact Project September 21, 2017 Integrated Network Summit Presented by: Mark Earnest, MD, PhD Lauren Drake, Wagner Schorr-Ratzlaff MD, Huong Lam MD, Laurence Williams MD, Mary McCord MD,


slide-1
SLIDE 1

Division of General Internal Medicine Hypertension Impact Project

September 21, 2017 Integrated Network Summit

Presented by: Mark Earnest, MD, PhD

Lauren Drake, Wagner Schorr-Ratzlaff MD, Huong Lam MD, Laurence Williams MD, Mary McCord MD, Hillary Chrastil MHA, Mary Kozloski, Carmen L. Lewis MD, MPH

slide-2
SLIDE 2

Background

  • Goal: To achieve 70% hypertension control across both our General

Internal Medicine practices.

  • Strategy: Five evidence-based domains with 1-3 strategies each
  • Setting
  • Anschutz Internal Medicine ~ 4,700
  • Lowry Internal Medicine ~ 2,400
slide-3
SLIDE 3
slide-4
SLIDE 4

Results

slide-5
SLIDE 5

33% 63%

67% 37%

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

February, 2016 June, 2017

Anschutz Internal Medicine

Providers with 70% Control or Greater Providers with Less than 70% Control

27% 88%

73% 12% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% February, 2016 June, 2017

Lowry Internal Medicine

Providers with 70% Control or Greater Providers with Less than 70% Control

slide-6
SLIDE 6

EDUCATION

Patient Education Materials Quarterly BP Measurement Technique Trainings

  • Medical Assistants (MAs)

participate in ongoing educational sessions

  • Includes:
  • Overview of BP
  • Cuff sizing
  • Patient positioning
  • Automatic BP machines
  • Manual readings
slide-7
SLIDE 7

Previous outreach criteria:

  • Patients age 18-59
  • Last BP > 140/90
  • Average of the last 3 BP Readings > 150/90
  • Last PCP visit 6 months ago or longer

Expanded outreach criteria:

  • Patients age 18-59
  • Last BP >140/90
  • Average of the last 3 BP readings > 140/90
  • Last PCP visit 3 months ago or longer

269 504 280 95 100 200 300 400 500 600 700 Lowry (n=549) Anschutz (n=599)

Outreach Results

Attempted Resulted in Visit

OUTREACH

slide-8
SLIDE 8

Anschutz

  • Pharmacy
  • Recheck & review
  • Encourage Self-monitoring

Lowry

  • Physician paired with a trained RN
  • Collaborate & manage complex hypertensive

patients

  • RN provides education & support via telephone

/ MHC

  • Recheck & review

AHA HBP Algorithm Including:

  • Patient education
  • Medication titration
  • Lifestyle modifications

TREATMENT & COUNSELING

slide-9
SLIDE 9

SELF MONITORING

No Co-Pay BP Checks Home BP Checks

  • Encouraged self-monitoring as part of

treatment via the MD/ RN HTN clinic and the Pharmacy HTN clinic

Summary n % Total # no-charge BP Checks 94 # Unique patients 84 BP =< 140/90 57 60.6% Escalated to RN 32 34.0% Escalated to MD 2 2.1% Sent to ED 1 1.1%

slide-10
SLIDE 10

CURRENT FACULTY

# Patients age 18<=59 # with BP <= 140/90 # pts uncontrolled # additional controlled pts to meet goal % <= 140/90 Goal

Johnson, Michelle 20 16 4

  • 80.00%

70.00% Jordan, Michael 87 69 18

  • 79.31%

70.00% Doe, Jane 12 9 3

  • 75.00%

70.00% Test, Doctor 33 24 9

  • 72.73%

70.00% Lee, NP 11 8 3

  • 72.73%

70.00% Green, Mario 57 41 16

  • 71.93%

70.00% Red, Allison 14 10 4

  • 71.43%

70.00% ALL 796 538 258 20 67.59% 70.00% Diaz, Director 77 52 25 2 67.53% 70.00% Day, Dean 91 61 30 3 67.03% 70.00% Physician, Miss 24 15 9 2 62.50% 70.00% RESIDENTS 144 88 56 13 61.11% 70.00% Last, First 61 37 24 6 60.66% 70.00% Name, Name 12 6 6 3 50.00% 70.00%

AUDIT & FEEDBACK

LOWRY IM OP TEST, DOCTOR NO TEST, PATIENT 888888 53 12/11/2015 06/16/2015 152 96 132 LOWRY IM OP TEST, DOCTOR YES JOHNSON, TEST 222222 62 6/24/2015 09/09/2014 133 80 144 LOWRY IM OP TEST, DOCTOR YES DOE, JANE 131313 68 6/17/2015 06/17/2015 138 75 143

# Patients with HTN: 3 # Patients with last BP <= 140/90 2 % Patients with last BP <= 140/90 66.67%

Last Practice Visit Last PCP Visit Last BP Systolic Last BP Diastolic Average BP Systolic Department Provider BP < 140/90 Patient Name MRN Age

slide-11
SLIDE 11

AUDIT & FEEDBACK

54.55% 50.89% 51.72% 57.63% 56.14% 52.78% 57.02% 54.10% 61.11% 68.24% 71.71% 56.39% 60.33% 58.90% 57.96% 62.62% 56.02% 52.17% 53.61% 59.73% 61.75% 66.07% 40.00% 45.00% 50.00% 55.00% 60.00% 65.00% 70.00% 75.00% 80.00% Feb-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun '17

Resident Hypertension Control (Ages 18-59)

LOWRY RESIDENTS ANSCHUTZ RESIDENTS

slide-12
SLIDE 12

Uncontrolled Patients: A Deep Dive

144, 83% 29, 17% Hypertensive Patients with Uncontrolled BP (N=173)

Uncontrolled patients who are NOT actionable Uncontrolled patients who are actionable and may benefit from an intervention

47, 33% 35, 24% 28, 19% 14, 10% 13, 9% 4, 3% 2, 1% 1, 1%

Reasons Patients Were Not Actionable (N = 144)

BP is adequately controlled in Primary Care/ home measurement Patient did not follow up Provider is actively intervening

  • n patient. (lifestyle

modifications or med titration) Following PCP's most recent intervention, BP is now controlled Medication non-adherence Other medical issues have taken priority No longer a patient with this provider/ clinic Patient refused intervention

slide-13
SLIDE 13

In In Summary ry

  • Push individualized bi-monthly data to providers
  • Focused work with residents
  • Patient education materials
  • Training for MAs
  • Outreach
  • AHA HBP Algorithm
  • No co-pay BP checks
  • Home BP monitoring
slide-14
SLIDE 14

Lessons Learned

  • Pursue improvement in multiple domains
  • Monitoring the multiple data streams used to support hypertension

improvement is key for improvement work

  • Accurate panel attribution is imperative
  • Pushing actionable patient-level data is a meaningful exercise
slide-15
SLIDE 15

Future Applications for Population Health

Providers receive actionable patient-level data Dashboard Automated process to push data

slide-16
SLIDE 16

Discussion